Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
118
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons

Gabriel Tremblay1 Purple Squirrel Economics, New York, NY, USACorrespondence[email protected]
,
Tracy Westley1 Purple Squirrel Economics, New York, NY, USA
,
Joseph C Cappelleri2 Pfizer Inc, New York, NY, USA
,
Bhakti Arondekar2 Pfizer Inc, New York, NY, USA
,
Geoffrey Chan2 Pfizer Inc, New York, NY, USA
,
Timothy J Bell2 Pfizer Inc, New York, NY, USA
&
Andrew Briggs3 William R Lindsay Chair of Health Economics, Health Economics and Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK
 show all
Pages 551-565 | Published online: 06 Sep 2019

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sunil Girish Iyer, Michele Stanchina, Terrence J Bradley & Justin Watts. (2022) Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date. Cancer Management and Research 14, pages 2267-2272.
Read now

Articles from other publishers (6)

Cyril Fersing & Fanny Mathias. (2022) Update on glasdegib in acute myeloid leukemia – broadening horizons of Hedgehog pathway inhibitors. Acta Pharmaceutica 72:1, pages 9-34.
Crossref
Yao Jiang, Andrew D. Southam, Sandro Trova, Flavio Beke, Bader Alhazmi, Thomas Francis, Anshul Radotra, Alessandro di Maio, Mark T. Drayson, Chris M. Bunce & Farhat L. Khanim. (2021) Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing. British Journal of Cancer 126:2, pages 275-286.
Crossref
Lamia Madaci, Julien Colle, Geoffroy Venton, Laure Farnault, Béatrice Loriod & Régis Costello. (2021) The contribution of single-cell analysis of acute leukemia in the therapeutic strategy. Biomarker Research 9:1.
Crossref
Eric Solary & Raphael Itzykson. (2021) Chronic Myelomonocytic Leukemia Gold Jubilee. Hemato 2:3, pages 403-428.
Crossref
Gabriel Tremblay, Patrick Daniele, Timothy Bell, Geoffrey Chan, Andrew Brown & Joseph C Cappelleri. (2021) Comparative effectiveness of glasdegib versus venetoclax combined with low-dose cytarabine in acute myeloid leukemia. Journal of Comparative Effectiveness Research 10:7, pages 603-612.
Crossref
Gabriel Tremblay, Dimitrios Tomaras, Eric Strati & Anna Forsythe. (2021) Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons. Journal of Health Economics and Outcomes Research 8:1, pages 10-17.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.